Mivudvir HBV ®
Composition:
Lamivudine 100 mg
Indication
Treatment of Chronic Hepatitis B Infection
Dosage and administration
- In adults the recommended oral dose of Mivudvir HBV 100 mg Tablets for treatment of chronic hepatitis B in adults is 100 mg (one – tablet) once daily. Safety and effectiveness of treatment beyond 1 year have not been established and the optimum .duration of treatment is not known the formulation and dosage of lamivudine in Mivudvir HBV 100 mg Tablets are not appropriate for patients dually – infected with HBV and HIV. If lamivudine is administered to such patients, the higher dosage indicated for HIV therapy should be used as part of an appropriate combination regimen, and the prescribing information for Mivudvir 150 mg .Tablets as well as Mivudvir HBV 100 mg Tablets should be consulted 2- Pediatric Patients: The recommended oral dose for pediatric patients 2 to 17 years of age with chronic hepatitis B is 3 mg/kg once daily up to a maximum daily dose of 100 mg. Safety and effectiveness of treatment beyond 1 year have not .been established and the optimum duration of treatment is not known
Package and storage
Carton box containing one blister (PVC/Alu) of 10 tablets and insert leaflet –
Store at temperature not exceeding 30 °C, in a dry place.
To be used under physician supervision – .Keep all medicaments out of reach of children
inquiry